Literature DB >> 23522057

Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different.

A Owoso1, C S Carter, J M Gold, A W MacDonald, J D Ragland, S M Silverstein, M E Strauss, D M Barch.   

Abstract

BACKGROUND: Cognition is increasingly being recognized as an important aspect of psychotic disorders and a key contributor to functional outcome. In the past, comparative studies have been performed in schizophrenia and schizo-affective disorder with regard to cognitive performance, but the results have been mixed and the cognitive measures used have not always assessed the cognitive deficits found to be specific to psychosis. A set of optimized cognitive paradigms designed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia (CNTRACS) Consortium to assess deficits specific to schizophrenia was used to measure cognition in a large group of individuals with schizophrenia and schizo-affective disorder.
METHOD: A total of 519 participants (188 with schizophrenia, 63 with schizo-affective disorder and 268 controls) were administered three cognitive paradigms assessing the domains of goal maintenance in working memory, relational encoding and retrieval in episodic memory and visual integration.
RESULTS: Across the three domains, the results showed no major quantitative differences between patient groups, with both groups uniformly performing worse than healthy subjects.
CONCLUSIONS: The findings of this study suggests that, with regard to deficits in cognition, considered a major aspect of psychotic disorder, schizophrenia and schizo-affective disorder do not demonstrate major significant distinctions. These results have important implications for our understanding of the nosological structure of major psychopathology, providing evidence consistent with the hypothesis that there is no natural distinction between cognitive functioning in schizophrenia and schizo-affective disorder.

Entities:  

Mesh:

Year:  2013        PMID: 23522057      PMCID: PMC4149253          DOI: 10.1017/S0033291713000536

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  50 in total

1.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  The clinical translation of a measure of gain control: the contrast-contrast effect task.

Authors:  Deanna M Barch; Cameron S Carter; Steve C Dakin; James Gold; Steven J Luck; Angus Macdonald; John D Ragland; Steven Silverstein; Milton E Strauss
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

3.  A comparison of basic and social cognition between schizophrenia and schizoaffective disorder.

Authors:  Joanna M Fiszdon; Randall Richardson; Tamasine Greig; Morris D Bell
Journal:  Schizophr Res       Date:  2007-01-26       Impact factor: 4.939

Review 4.  Performance-based measures of functional skills: usefulness in clinical treatment studies.

Authors:  Philip D Harvey; Dawn I Velligan; Alan S Bellack
Journal:  Schizophr Bull       Date:  2007-05-09       Impact factor: 9.306

Review 5.  CNTRICS final task selection: long-term memory.

Authors:  John D Ragland; Roshan Cools; Michael Frank; Diego A Pizzagalli; Alison Preston; Charan Ranganath; Anthony D Wagner
Journal:  Schizophr Bull       Date:  2008-10-16       Impact factor: 9.306

6.  The dot pattern expectancy task: reliability and replication of deficits in schizophrenia.

Authors:  Jessica A H Jones; Scott R Sponheim; Angus W MacDonald
Journal:  Psychol Assess       Date:  2010-03

7.  Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder.

Authors:  Daniel H Mathalon; Ralph E Hoffman; Todd D Watson; Ryan M Miller; Brian J Roach; Judith M Ford
Journal:  Front Hum Neurosci       Date:  2010-01-29       Impact factor: 3.169

8.  Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.

Authors:  Matthew J Smith; Deanna M Barch; John G Csernansky
Journal:  Schizophr Res       Date:  2008-09-10       Impact factor: 4.939

9.  Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.

Authors:  Abraham Reichenberg; Philip D Harvey; Christopher R Bowie; Ramin Mojtabai; Jonathan Rabinowitz; Robert K Heaton; Evelyn Bromet
Journal:  Schizophr Bull       Date:  2008-05-20       Impact factor: 9.306

Review 10.  Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.

Authors:  Michael F Green; Pamela D Butler; Yue Chen; Mark A Geyer; Steven Silverstein; Jonathan K Wynn; Jong H Yoon; Vance Zemon
Journal:  Schizophr Bull       Date:  2008-11-20       Impact factor: 9.306

View more
  11 in total

1.  Explicit and implicit reinforcement learning across the psychosis spectrum.

Authors:  Deanna M Barch; Cameron S Carter; James M Gold; Sheri L Johnson; Ann M Kring; Angus W MacDonald; Diego A Pizzagalli; J Daniel Ragland; Steven M Silverstein; Milton E Strauss
Journal:  J Abnorm Psychol       Date:  2017-04-13

2.  Cognitive impairments in psychotic disorders: common mechanisms and measurement.

Authors:  Deanna M Barch; Julia M Sheffield
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

3.  Multiple forms of contour grouping deficits in schizophrenia: what is the role of spatial frequency?

Authors:  Brian P Keane; Gennady Erlikhman; Sabine Kastner; Danielle Paterno; Steven M Silverstein
Journal:  Neuropsychologia       Date:  2014-11-01       Impact factor: 3.139

Review 4.  Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.

Authors:  James L Reilly; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-02-26       Impact factor: 9.306

5.  Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity.

Authors:  Erin W Tuplin; Matthew R Holahan
Journal:  Curr Neuropharmacol       Date:  2017-11-14       Impact factor: 7.363

6.  Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder.

Authors:  Julia Ermel; Cameron S Carter; James M Gold; Angus W MacDonald; J Daniel Ragland; Steven M Silverstein; Milton E Strauss; Deanna M Barch
Journal:  Schizophr Res Cogn       Date:  2017-05-09

7.  Cross-diagnostic analysis of cognitive control in mental illness: Insights from the CNTRACS consortium.

Authors:  Jason Smucny; Deanna M Barch; James M Gold; Milton E Strauss; Angus W MacDonald; Megan A Boudewyn; J Daniel Ragland; Steven M Silverstein; Cameron S Carter
Journal:  Schizophr Res       Date:  2019-01-28       Impact factor: 4.939

Review 8.  Memory and cognition in schizophrenia.

Authors:  J Y Guo; J D Ragland; C S Carter
Journal:  Mol Psychiatry       Date:  2018-09-21       Impact factor: 15.992

9.  Cognitive and clinical predictors of community functioning across the psychoses.

Authors:  Kathryn E Lewandowski; Talia R Cohen; Dost Ongur
Journal:  Psych J       Date:  2020-03-24

10.  Retrieval practice facilitation of family psychoeducation in people with early psychosis.

Authors:  J Daniel Ragland; Xiaonan L Liu; Ashley B Williams; Laura M Tully; Tara A Niendam; Cameron S Carter; Charan Ranganath
Journal:  Schizophr Res       Date:  2020-07-29       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.